Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-fluorouracil + sodium hyaluronate + microneedling
- Development stage
- Unknown
- Lead developer
- Affiliated Hospital of Southwest Medical University
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical, Transdermal
01
Overview
5-fluorouracil + sodium hyaluronate + microneedling (often abbreviated as 5-FU + SHS + MUCA) is an investigational combination therapy designed for the treatment of hypertrophic scars. The therapy utilizes a spreadable sodium hyaluronate-based hydrogel (SHS) as a high-efficiency transdermal drug delivery system for the antimetabolite 5-fluorouracil (5-FU). The delivery process is enhanced by microneedling (referred to as MUCA in clinical trial contexts), which creates micro-channels in the skin to facilitate deeper and more uniform penetration of the 5-FU formulation. The active pharmaceutical ingredient, 5-fluorouracil, works by inhibiting thymidylate synthase, an enzyme essential for DNA synthesis. This inhibition suppresses the excessive proliferation of fibroblasts and the overproduction of collagen, which are the primary drivers of hypertrophic scar formation. This therapeutic approach is currently being evaluated in clinical trials led by researchers at The Affiliated Hospital of Southwest Medical University and Xiamen University.
- Other names
- 5-fluorouracil + sodium hyaluronate + Mucaine5-FU + SHS + MUCA therapy
02
Targets
TS (Thymidylate synthase)
Beyond the preview
Go deeper on 5-fluorouracil + sodium hyaluronate + microneedling.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-fluorouracil + sodium hyaluronate + microneedling.